Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus

被引:151
作者
Gomi, Y
Sunamachi, H
Mori, Y
Nagaike, K
Takahashi, M
Yamanishi, K
机构
[1] Osaka Univ, Sch Med, Dept Microbiol, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Res Fdn Microbial Dis, Kanonji Inst, Kagawa, Japan
[3] Osaka Univ, Res Fdn Microbial Dis, Osaka, Japan
关键词
D O I
10.1128/JVI.76.22.11447-11459.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The DNA sequences of the Oka varicella vaccine virus (V-Oka) and its parental virus (P-Oka) were completed. Comparison of the sequences revealed 42 base substitutions, which led to 20 amino acid conversions and length differences in tandem repeat regions (R1, R3, and R4) and in an origin of DNA replication. Amino acid substitutions existed in open reading frames (ORFs) 6, 9A, 10, 21, 31, 39, 50, 52, 55, 59, 62, and 64. Of these, 15 base substitutions, leading to eight amino acid substitutions, were in the gene 62 region alone. Further DNA sequence analysis showed that these substitutions were specific for V-Oka and were not present in nine clinical isolates. The immediate-early gene 62 product (IE62) of P-Oka had stronger transactivational activity than the mutant IE62 contained in V-Oka in 293 and CV-1 cells. An infectious center assay of a plaque-purified clone (S7-01) from the V-Oka with 8 amino acid substitutions in ORF 62 showed smaller plaque formation and less-efficient virus-spreading activity than did P-Oka in human embryonic lung cells. Another clone (S-13) with only five substitutions in ORF 62 spread slightly faster than S7-01 but not as effectively as P-Oka. Moreover, transient luciferase assay in 293 cells showed that transactivational activities of IE62s of S7-01 and S7-13 were lower than that of P-Oka. Based on these results, it appears that amino acid substitutions in ORF 62 are responsible for virus growth and spreading from infected to uninfected cells. Furthermore, the Oka vaccine virus was completely distinguishable from P-Oka and 54 clinical isolates by seven restriction-enzyme fragment length polymorphisms that detected differences in the DNA sequence.
引用
收藏
页码:11447 / 11459
页数:13
相关论文
共 72 条
[51]   A MAJOR TRANSACTIVATOR OF VARICELLA-ZOSTER VIRUS, THE IMMEDIATE-EARLY PROTEIN IE62, CONTAINS A POTENT N-TERMINAL ACTIVATION DOMAIN [J].
PERERA, LP ;
MOSCA, JD ;
RUYECHAN, WT ;
HAYWARD, GS ;
STRAUS, SE ;
HAY, J .
JOURNAL OF VIROLOGY, 1993, 67 (08) :4474-4483
[52]   THE VARICELLA-ZOSTER VIRUS IMMEDIATE EARLY PROTEIN, IE62, CAN POSITIVELY REGULATE ITS COGNATE PROMOTER [J].
PERERA, LP ;
MOSCA, JD ;
SADEGHIZADEH, M ;
RUYECHAN, WT ;
HAY, J .
VIROLOGY, 1992, 191 (01) :346-354
[53]   The TATA motif specifies the differential activation of minimal promoters by varicella zoster virus immediate-early regulatory protein IE62 [J].
Perera, LP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) :487-496
[54]   Disruption of the varicella-zoster virus dUTPase and the adjacent ORF9A gene results in impaired growth and reduced syncytia formation in vitro [J].
Ross, J ;
Williams, M ;
Cohen, JI .
VIROLOGY, 1997, 234 (02) :186-195
[55]   Transmission of varicella vaccine virus from a healthy 12-month old child to his pregnant mother [J].
Salzman, MB ;
Sharrar, RG ;
Steinberg, S ;
LaRussa, P .
JOURNAL OF PEDIATRICS, 1997, 131 (01) :151-154
[56]  
Schoonbroodt S, 1996, J MED VIROL, V49, P264, DOI 10.1002/(SICI)1096-9071(199608)49:4<264::AID-JMV2>3.0.CO
[57]  
2-1
[58]   Infection of human T lymphocytes with varicella-zoster virus: An analysis with viral mutants and clinical isolates [J].
Soong, W ;
Schultz, JC ;
Patera, AC ;
Sommer, MH ;
Cohen, JI .
JOURNAL OF VIROLOGY, 2000, 74 (04) :1864-1870
[59]   IDENTIFICATION OF A VARICELLA-ZOSTER VIRUS ORIGIN OF DNA-REPLICATION AND ITS ACTIVATION BY HERPES-SIMPLEX VIRUS TYPE-1 GENE-PRODUCTS [J].
STOW, ND ;
DAVISON, AJ .
JOURNAL OF GENERAL VIROLOGY, 1986, 67 :1613-1623
[60]   IDENTIFICATION OF VARICELLA-ZOSTER VIRUS-STRAINS BY PCP ANALYSIS OF 3 REPEAT ELEMENTS AND A PSTI-SITE-LESS REGION [J].
TAKADA, M ;
SUZUTANI, T ;
YOSHIDA, I ;
MATOBA, M ;
AZUMA, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (03) :658-660